Skip to Main Content

1,294

Views

2

CrossRef citations to date

0

Altmetric

Rheumatoid Arthritis

A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate

Tsutomu Takeuchia Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information

,

Yoshiya Tanakab The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, JapanView further author information

,

Chieri Higashitanic Clinical Development, Astellas Pharma, Inc., Tokyo, JapanView further author information

,

Megumi Iwaid Clinical Pharmacology and Exploratory Development, Astellas Pharma, Inc., Tokyo, JapanView further author information

,

Kanji Komatsue Clinical Pharmacology, Astellas Pharma, Inc., Tokyo, JapanView further author information

,

Rio Akazawaf Data Science, Astellas Pharma, Inc., Tokyo, JapanView further author information

&

Christopher Lademacherg Medical Science, Astellas Pharma, Inc., Northbrook, IL, USAView further author information